Radiolabeling of magnetic targeted carriers (MTC) with indium-111

被引:10
|
作者
Häfeli, UO
Yu, JF
Farudi, F
Li, YH
Tapolsky, G
机构
[1] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA
[2] Chinese Acad Sci, Shanghai Inst Nucl Res, Shanghai 201800, Peoples R China
[3] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
[4] FeRx Inc, Aurora, CO 80010 USA
关键词
magnetic targeting; microspheres; radiolabeling; indium-111; yttrium-90; imaging;
D O I
10.1016/S0969-8051(03)00077-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Magnetic targeted carriers (MTC) are magnetically susceptible microparticles that can be physically targeted to a specific site. MTC were radiolabeled with In-111 using three different methods. Reaction parameters were investigated in order to optimize the final properties of the labeled MTC. The reaction parameters studied were chelation agent, chelation time, temperature, radiolabeling time, solvent, and molar ratios. A 97.7 +/- 0.9% binding efficiency and plasma stability of 92.6 +/- 0.1% over 7 days were achieved when 2-p-aminobenzyl-1,4,7, 10-tetraazacyclododecane-1,4,7,10-tetra-acetic acid (ABz-DOTA) was used as the chelating agent. A preliminary animal biodistribution study confirmed the binding stability. The labeling of the MTC with the diagnostic isotope In-111 was undertaken to allow for quantitative imaging and dosimetry prior to therapy with Y-90 radiolabeled MTC. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 50 条
  • [21] Indium-111 capromab pendetide (ProstaScint) uptake in a meningioma
    Zucker, RJ
    Bradley, YC
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (06) : 568 - 569
  • [22] PREPARATION OF INDIUM-111 LABELED BLEOMYCIN FOR TUMOR LOCALIZATION
    THAKUR, ML
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1973, 24 (06): : 357 - 359
  • [23] CYCLOTRON PRODUCTION OF CARRIER-FREE INDIUM-111
    BROWN, LC
    BEETS, AL
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1972, 23 (02): : 57 - &
  • [24] Indium-111 granulocyte scintigraphy in inflammatory bowel disease
    Devillers, A
    Moisan, A
    Heresbach, D
    Darnault, P
    Bretagne, JF
    MEDECINE NUCLEAIRE, 1996, 20 (2-3): : 243 - 246
  • [25] Indium-111 leukocyte scintigraphy in suspected bowel ischemia
    Dhekne, RD
    Chatziioannou, SN
    Moore, WH
    Ford, PV
    Hochman, FL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (08): : 1983 - 1989
  • [26] INDIUM-111 BLEOMYCIN SCANNING IN EVALUATION OF MALIGNANT-MELANOMA
    HORN, NL
    VERMA, RC
    BENNETT, LR
    JOURNAL OF NUCLEAR MEDICINE, 1975, 16 (06) : 537 - 537
  • [27] INDIUM-111 BLEOMYCIN AS A TUMOR SCANNING AGENT IN PEDIATRIC ONCOLOGY
    OMARA, RE
    HABER, K
    CORRIGAN, J
    JOHNSON, H
    LILIEN, DL
    JOURNAL OF NUCLEAR MEDICINE, 1975, 16 (06) : 554 - 554
  • [28] METHODS FOR COMPACT CYCLOTRON PRODUCTION OF INDIUM-111 FOR MEDICAL USE
    MACDONALD, NS
    NEELY, HH
    WOOD, RA
    TAKAHASHI, JM
    WAKAKUWA, SI
    BIRDSALL, RL
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1975, 26 (10): : 631 - 633
  • [29] Thrombophlebitis diagnosed on indium-111 labelled white cell scan
    English, PJ
    Eyes, BE
    Gill, G
    BRITISH JOURNAL OF RADIOLOGY, 2004, 77 (920): : 679 - +
  • [30] Validation of the Monte Carlo simulator GATE for indium-111 imaging
    Assié, K
    Gardin, I
    Véra, P
    Buvat, I
    PHYSICS IN MEDICINE AND BIOLOGY, 2005, 50 (13): : 3113 - 3125